Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-01-31 4:39 pm Purchase |
2022-01-21 | 13G | Kura Oncology, Inc. KURA |
EcoR1 Capital LLC | 4,543,447 6.800% |
2,770,410 (+156.25%) |
Filing History |
| 2022-01-13 6:45 pm Purchase |
2022-01-12 | 13D | Prothena Corporation plc PRTA |
EcoR1 Capital LLC | 11,584,280 24.900% |
2,157,640 (+22.89%) |
Filing History |
| 2021-12-10 5:24 pm Sale |
2021-12-10 | 13G | Odonate Therapeutics, Inc. ODTC |
EcoR1 Capital LLC | 0 0.000% |
-0 (Position Closed) |
Filing History |
| 2021-12-10 5:08 pm Purchase |
2021-12-01 | 13G | Atea Pharmaceuticals, Inc. AVIR |
EcoR1 Capital LLC | 5,376,134 6.500% |
5,376,134 (New Position) |
Filing History |
| 2021-11-18 1:03 pm Purchase |
2021-11-17 | 13G | Odonate Therapeutics, Inc. ODTC |
EcoR1 Capital LLC | 0 14.800% |
0 (+69.51%) |
Filing History |
| 2021-11-16 12:20 pm Purchase |
2021-11-05 | 13G | 2seventy bio, Inc. TSVT |
EcoR1 Capital LLC | 1,890,663 8.100% |
1,890,663 (New Position) |
Filing History |
| 2021-10-22 4:46 pm Purchase |
2021-10-12 | 13G | Voyager Therapeutics, Inc. VYGR |
EcoR1 Capital LLC | 3,557,507 9.400% |
3,557,507 (New Position) |
Filing History |
| 2021-10-05 1:03 pm Sale |
2021-09-30 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
EcoR1 Capital LLC | 81,077 0.200% |
-5,000,000 (-98.40%) |
Filing History |
| 2021-09-23 3:14 pm Purchase |
2021-09-22 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
EcoR1 Capital LLC | 5,081,077 12.000% |
1,501,700 (+41.95%) |
Filing History |
| 2021-07-19 5:23 pm Purchase |
2021-07-08 | 13G | Odonate Therapeutics, Inc. ODTC |
EcoR1 Capital LLC | 0 8.700% |
0 (New Position) |
Filing History |
| 2021-07-19 5:16 pm Purchase |
2021-07-09 | 13G | Arcus Biosciences, Inc. RCUS |
EcoR1 Capital LLC | 4,572,047 6.400% |
4,572,047 (New Position) |
Filing History |
| 2021-07-12 1:26 pm Purchase |
2021-07-02 | 13G | Alector, Inc. ALEC |
EcoR1 Capital LLC | 4,742,634 6.000% |
4,742,634 (New Position) |
Filing History |
| 2021-05-17 5:16 pm Purchase |
2021-05-06 | 13G | Shattuck Labs, Inc. STTK |
EcoR1 Capital LLC | 3,295,088 7.900% |
3,295,088 (New Position) |
Filing History |
| 2021-05-11 4:08 pm Purchase |
2021-05-04 | 13D | AnaptysBio, Inc. ANAB |
EcoR1 Capital LLC | 7,520,424 27.500% |
368,800 (+5.16%) |
Filing History |
| 2021-05-11 4:06 pm Purchase |
2021-05-04 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
EcoR1 Capital LLC | 3,579,377 8.500% |
3,579,377 (New Position) |
Filing History |
| 2021-04-12 5:45 pm Unchanged |
2021-04-08 | 13D | AnaptysBio, Inc. ANAB |
EcoR1 Capital LLC | 7,151,624 26.100% |
0 (Unchanged) |
Filing History |
| 2021-03-10 5:17 pm Purchase |
2021-03-08 | 13D | AnaptysBio, Inc. ANAB |
EcoR1 Capital LLC | 7,151,624 26.100% |
3,338,300 (+87.54%) |
Filing History |
| 2021-02-16 12:16 pm Sale |
2020-12-31 | 13G | Surface Oncology, Inc. SURF |
EcoR1 Capital LLC | 48,558 0.100% |
-4,985,303 (-99.04%) |
Filing History |
| 2021-02-16 12:11 pm Purchase |
2020-12-31 | 13G | Solid Biosciences Inc. SLDB |
EcoR1 Capital LLC | 531,847 9.400% |
180,180 (+51.24%) |
Filing History |
| 2021-02-16 12:10 pm Purchase |
2020-12-31 | 13G | Avidity Biosciences, Inc. RNA |
EcoR1 Capital LLC | 2,103,950 5.600% |
2,103,950 (New Position) |
Filing History |